Zhitong Finance App News, Ted Pharmaceuticals (03880) issued an announcement. On August 27, 2026, the board of directors passed a resolution recommending the adoption of restricted share unit plans; and recommending the adoption of sub-limits for service providers.

The purpose of the Restricted Share Unit Program is to: (1) recognize the contributions of a number of participants and provide them with rewards to retain them for the Group's continued operation and development; (2) attract suitable candidates to help the Group further develop.

In view of the expansion of the scope of eligible participants to include service providers, the Board considers that it is appropriate to adopt sub-limits for service providers within the authorized limits of the scheme, as required by section 17.03A (1) of the Listing Rules.

Therefore, the total number of rewards granted to service providers from time to time under the restricted share unit scheme must not exceed 1% of the total number of shares issued as of the date of adoption (excluding treasury shares, if any). Therefore, the service provider sub-limit relating to the restricted share unit plan should be 1,418,000 shares, or 1% of the total number of issued shares (excluding treasury shares, if any) as of the date of adoption (assuming that the Company did not issue or repurchase new shares before the Extraordinary General Meeting of Shareholders).

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.